The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 229.00
Bid: 228.00
Ask: 230.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.877%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 229.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

14 Jun 2022 07:00

RNS Number : 7203O
Spectra Systems Corporation
14 June 2022
 

Spectra Systems Corporation

("The Company" or "Spectra Systems")

Appointment of Chief Financial Officer

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies and gaming security software is delighted to announce that it has agreed to appoint Colleen Hamill, C.P.A. (aged 56) as its new Chief Financial Officer.

Colleen Hamill started her career in 1987 at KPMG Peat Marwick in public accounting prior to working as an Accounting Manager at HMK Enterprises, Inc. an $820MM diversified holding company from 1990 to 1996. From 1996 to 2007, Ms. Hamill was the Global Corporate Controller and a member of the senior management at Brewster Wallcovering, a global distributer and manufacturer of wall covering and related products. Following this position, she held the position of Senior Director of Corporate Accounting at GTECH (now IGT) for eight months before moving to the position of Senior Manager for Financial Reporting at Brookfield Renewable Power, a $12B operator and developer of hydroelectric power facilities. From 2010 to 2015, Ms. Hamill was the Global Manager for consolidations at Covidien, a $10B medical devices company. From this position, she has worked as the Finance Leader in the US operations of Boston-Power, a venture capital-backed developer and manufacturer of lithium-ion batteries and most recently as the Global Controller at Harvard Biosciences.

This announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

Colleen Hamill has confirmed that there is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

 

Dr. Nabil Lawandy, CEO of Spectra Systems, stated: "I am delighted to welcome Colleen to Spectra Systems and believe that her extensive financial experience, particularly in technology driven companies will be of immense value to us."

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer

Tel: +1 (0)401 274 4700

 

WH Ireland Limited (Nominated Adviser and Broker)

Chris Fielding (Head of Corporate Finance)

Andrew de Andrade (Executive, Corporate Finance) 

 

Allenby Capital Limited (Joint Broker)

Nick Naylor/James Reeve (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking) 

Tel: +44 (0)20 7220 1650

 

 

 

Tel: +44 (0)20 3328 5665

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSFMFADEESEFM
Date   Source Headline
28th Nov 20127:00 amRNSNotice of AGM
28th Nov 20127:00 amRNSDirector Shareholding
27th Nov 20127:00 amRNSRemoval of Restictions From Common Stock
13th Nov 20127:00 amRNSRemoval of Restrictions From Common Stock
1st Nov 20127:00 amRNSDirector Shareholding
31st Oct 20127:00 amRNSDirector Shareholding
23rd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
16th Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
2nd Oct 20127:00 amRNSRemoval of Restrictions From Common Stock
28th Sep 20127:00 amRNSInterim results for the 6 months ended 30 Jun 2012
27th Sep 20127:00 amRNSNew Contract Agreement
18th Sep 20127:00 amRNSRemoval of Restrictions From Common Stock
31st Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
29th Aug 20127:00 amRNSRemoval of Restrictions From Common Stock
21st Aug 20127:00 amRNSRemoval of Restrictions from Common Stock
13th Aug 20124:27 pmRNSRemoval of Restrictions From Common Stock
26th Jul 20127:00 amRNSShareholder Circular Posted
11th Jul 20127:00 amRNSDepositary Interest Facility & Admission to CREST
29th Jun 20124:17 pmRNSAnnual Financial Report
25th Jun 20127:00 amRNSStatement re share price movement
6th Jun 20127:00 amRNSAcquisition
19th Apr 20127:00 amRNSFinal Results
10th Apr 20127:00 amRNSNotice of Results
14th Feb 20127:00 amRNSDirectorate Change
10th Feb 20127:00 amRNSDirectorate Change
30th Sep 20117:00 amRNSInterim Results for the 6 months ended 30 Jun 2011
4th Aug 20117:00 amRNSShareholder Notifications
1st Aug 20117:00 amRNSShareholder Notifications
25th Jul 20117:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.